MOJ
eISSN: 2381-179X
Submit manuscript...
Case Report Volume 16 Issue 1
Treatment of facial infantile hemangioblastoma with local application of dobesilate cream
Pedro Cuevas, Javier Angulo
Received: December 12, 2025 | Published: January 9, 2026
Citation: Cuevas P, Angulo J. Treatment of facial infantile hemangioblastoma with local application of dobesilate cream. MOJ Clin Med Case Rep. 2026;16(1):4-5. DOI: 10.15406/mojcr.2026.16.00487
Abstract
Hemangioblastoma is a benign tumour. Fibroblast growth factor (FGF) plays an important role in the onset and progression of this condition. This study describes the efficacy and safety of application of dobesilate cream (an inhibitor of FGF) after 30 days of treatment in a child suffering a facial hemangioblastoma.
Keywords: hemangioblastoma, dobesilate, fibroblast growth factor, vascular endothelial growth factor
©2026 Cuevas, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.